Guidance for industry : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic.

Bibliographic Details
Corporate Authors:	United States. Food and Drug Administration. Office of Counterterrorism and Emerging Threats, Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), Center for Devices and Radiological Health (U.S.), Center for Food Safety and Applied Nutrition (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Center for Devices and Radiological Health : Center for Food Safety and Applied Nutrition, [2008]
Subjects:	Drugs > Side effects > Reporting > Government policy > United States. Dietary supplements > Government policy > United States. Influenza.
Online Access:	https://purl.fdlp.gov/GPO/LPS114222

Description
Item Description:	"Draft guidance". "Procedural". "December 2008". Title from PDF title page (viewed on July 2, 2009). Electronic resource.
Physical Description:	1 online resource (12 pages)